Hydrochlorothiazide Tablet
Product Images NDC 51655-422

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hydrochlorothiazide (04e2c83b 4c31 41f8 Bc75 F82ef1b30d07 01)

Chemical structure diagram of Hydrochlorothiazide showing its molecular formula (C7H8ClN3O4S2) and molecular weight (297.74). The structure includes a benzene ring substituted with chlorine, sulfonamide, and other functional groups.*

FDA Label Image

Company Logo (04e2c83b 4c31 41f8 Bc75 F82ef1b30d07 02)

FDA Label Image

Label (51655 422 26)

Label for Hydrochlorothiazide Tablets USP 50 mg oral tablets, containing 90 tablets per container. The label includes storage instructions to keep at controlled room temperature (20°-25°C) and a note that the product is prescription-only. It is manufactured and repackaged by Northwind Pharmaceuticals under Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.